Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Haruki Makioka"'
Autor:
Takafumi Wataya, Misuzu Hoshino, Sakura Takasaki, Naoto Matsuda, Haruki Makioka, Genshu Nakamura
Publikováno v:
The International journal of neuroscience.
Purpose Nusinersen is the first disease-modifying therapy to treat spinal muscular atrophy (SMA). This report describes the safety and effectiveness of nusinersen in Japanese clinical use using two data sources: an ongoing Japanese post-marketing sur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6bb517acc00321d69e5b099e7b6bf78
https://pubmed.ncbi.nlm.nih.gov/34809526
https://pubmed.ncbi.nlm.nih.gov/34809526
Autor:
Yukihiko Iizuka, Takahiko Saida, Kazumasa Yokoyama, Masakazu Hase, Shinichi Torii, Haruki Makioka, Ryusuke Sato, Yan Ling
Publikováno v:
Neurology and Therapy
Introduction Natalizumab, a humanized anti-α4 integrin monoclonal antibody, received marketing approval in Japan in 2014 for the treatment of multiple sclerosis (MS). Because the previous large-scale clinical trials of natalizumab were mainly conduc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c7aca8cb91e5d5a101b3606455ccfe3e
http://europepmc.org/articles/PMC5700906
http://europepmc.org/articles/PMC5700906
Publikováno v:
Rinsho Shinkeigaku. 57:553-561
To investigate the safety and effectiveness of the interferon β-1a intramuscular injection under clinical conditions in Japan, we conducted an all-case postmarketing surveillance with a 2-year follow-up of patients who were registered during the per
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2168b7795ce7c973167f8dd7bc9dd85
https://doi.org/10.5692/clinicalneurol.cn-001074
https://doi.org/10.5692/clinicalneurol.cn-001074
Publikováno v:
Clinical and Experimental Neuroimmunology. 7:59-65
Objectives To evaluate safety and efficacy of intramuscular interferon beta-1a (IFN beta-1a) in Japanese patients with relapsing–remitting multiple sclerosis over the first 2 years of treatment. Methods Safety data were collected from patients regi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::227ee752ced0767fb6e5ad1f73e57a39
https://doi.org/10.1111/cen3.12284
https://doi.org/10.1111/cen3.12284
Autor:
Takahiko Saida, Haruki Makioka, Yuko Shimizu, Naozumi Harada, Jun Ichi Kira, Shoko Nakabayashi
Publikováno v:
Clinical and Experimental Neuroimmunology. 6:402-408
Objectives To evaluate pregnancy outcomes in Japanese patients with multiple sclerosis (MS) enrolled in a postmarketing surveillance study of intramuscular interferon beta-1a (IM IFN beta-1a). Methods Safety data were collected from Japanese patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ed7df70bde6b9e0da0c525c084b9dad9
https://doi.org/10.1111/cen3.12231
https://doi.org/10.1111/cen3.12231